Inmune Bio Inc (INMB)

EBITDA Margin

-58952.00%

TTM · Period ending:

INMB logo

INMB EBITDA Margin

Latest reported-58952.00%
INMB TTM EBITDA Margin (-37983.78% → -58952.00%)
High-resolution chart · PNG

INMB ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Inmune Bio Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-58,952%
-66,972%
-78,184%
-81,514%
-300,064.2857%
-98,023.8095%
-34,267.0588%
-14,881.6794%
-5,486.4516%
-55.8036%
-32.2581%
0%
0%
4,697.5%
3,149.1573%
1,340%
2,517.1271%
-55,562.069%
-44,366.6667%
-14,052.06%
-37,983.7818%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.